Lumos Advances FebriDx Sales with iMedical Purchase Order
Filed with ASX · · 2 pages · English
Watch Lumos Diagnostics' latest callLumos Diagnostics Holdings (ASX:LDX) Q3 2026 Earnings Call · Replay · Apr 20Read the transcript of Lumos Diagnostics Holdings (ASX:LDX) Q3 2026 Earnings CallLumos Diagnostics Holdings Ltd. on 6ix
Story so far
Earlier from Lumos Diagnostics
- Lumos Secures Further US Medicare Reimbursement for FebriDx
- Lumos Secures Key US Reimbursement Milestones for FebriDx
- Hologic Development Agreement Expanded Scope of Works
- Commencement of FebriDx CLIA Waiver Study
- Lumos receives CPT PLA Code for FebriDX in the US
Later from Lumos Diagnostics
- Lumos Secures Fifth US Medicare Reimbursement for FebriDx
- Lumos Secures Sixth US Medicare Reimbursement for FebriDx
- Lumos Reaches Recruitment Milestone in FebriDx Study
- Lumos Reaches FebriDx CLIA Waiver Study Enrolment Milestone
- Pause in Trading
Follow Lumos Diagnostics into a list and get an email when it puts out news.
Follow Lumos Diagnostics